Serum amyloidogenic nanoplaques and cytokines in Alzheimer’s disease: A pilot study in a small naturalistic memory clinic cohort

Manuscript Number: 

21-5504R1

Author(s): 
Hans Christian D. Aass, Mari Aksnes, Nenad Bogdanovic, Anne-Brita Knapskog, Lars Terenius, Ann Tiiman, Vladana Vukojević

Disclosures

Hans Christian D. Aass

  • Nothing to Disclose

Mari Aksnes

  • Equity:
    I own 28 stocks in NYKODE THERAPEUTIC valued at 205 USD per 01/21/22.

Nenad Bogdanovic

  • Nothing to Disclose

Anne-Brita Knapskog

  • Patents/Royalties
    ABK has worked on clinical trials for Roche (BN29553), Boehringer-Ingelheim (1346.0023), and Novo Nordisk (NN6535-4730).

Lars Terenius

  • Nothing to Disclose

Ann Tiiman

  • Equity:
    Equity: Co-founder of AmyloiDia Sweden AB.
    Patents/Royalties
    Methods patent applicaton.

Vladana Vukojević

  • Equity:
    Co-founder of AmyloiDia Sweden AB and stock-holder.
    Patents/Royalties
    Patent application on the method.